Boat Bottoms, Barnacles and Modern Medicine:
Dan Rittschof Hopes the Drug Store Will Offer a Safe Substance
to Keep Barnacles Off Boats p.4
Jonathan R. Matias, who knows Rittschof and his antibiofouling
work well, also thinks the Duke researcher is on the right
track. Matias’ New York City-based company, Poseidon
Ocean Sciences, has been using Rittschof’s testing system
for years. He has identified a natural antifouling agent and
plans to register it with the EPA this year.
“The approach that Dan is doing is reasonable and hopefully
he will find some products that are low enough in cost and
approved by the EPA at the same time,” Matias said.
Earlier this year, Rittschof spent four weeks setting up
an antifouling lab at a brand new, palatial marine laboratory
nestled among the coconut trees of Singapore’s St. John’s
Island. For the next few years, Rittschof will shuttle between
North Carolina and Singapore to serve as adviser and collaborator.
The team set out to pinpoint metabolic pathways mutual to
both humans and barnacles. Then they targeted those that,
in the shellfish, serve as a key link in the biochemical events
that lead to its metamorphosis from swimming larvae to stubborn
barnacle. They were looking for drugs that, for example, interact
with the human opioid-2 pathway in both creatures. They tried
a range of common prescription and over-the-counter products
and found a few.
So, it was back to the barnacle larvae, known as nauplii.
After they shed their outer shells several times, the larvae
turn into “cyprids,” creatures that live on their
own fat. However, if cyprids don’t anchor themselves
to a hard surface within two weeks they die. Drawn by pheromones,
they seek out surfaces already colonized by other barnacles,
where they attach themselves and transform again, this time
into filter feeders.
Rittschof’s team was trying to find a way to spare
the nauplii, which are an important part of the maritime food
chain, but kill the cyprids before they could settle. So they
conducted a toxicity test by bathing the nauplii in drugs.
Since the larvae need to move at that stage in order to find
a place to settle, the researchers measure how much of the
drug they could handle without dying. If they stopped swimming,
it was too much. They then expose cyprids—settlement
stage larvae—to different concentrations of drugs to
see if they have any effect on its ability to settle. By combining
data from the two tests, they were able to come up with a
therapeutic ratio—in other words, enough to kill the
cyprids without killing the nauplii.
So the same dose that is safe for nauplii will kill a barnacle.
But, what else will it kill? Rittschof said that drugs have
the potential to be just as harmful to the marine environment
as metals. But because drug effects and fates are so well
studied in humans, they should have predictable lifetimes
in the environment.
“In a drug, you know the most likely place on a molecule
for a compound to break down,” he said. “You know
how it interacts with other compounds and you know what’s
been done to keep that from happening. There is just so much
more of a knowledge base because billions of dollars have
been spent on building drugs.”
This summer, Rittschof presented a paper on his work at the
11th International Congress on Marine Corrosion and Fouling,
an international scientific conference on the chemical and
biological deterioration of materials in the sea. Now, the
team Rittschof advises is ready to start engineering the technology.
To do that, they will be looking at the drug’s chemistry
to see if it can be made compatible with existing antifouling
coatings.
Informed by the lessons of the past, Rittschof is hoping
that he’ll have a head start this time.
“The next round we’ll become much more specific
in the way we work with things,” he said. “If
we really understand our chemistry, we shouldn’t have
to go back to the drawing board.”
Tinker Ready is a health and science writer
based in Cambridge, Mass. She writes regularly for Nature
Medicine, the Utne Reader and the
Los Angeles Times.
page 1 | 2
| 3 | 4
|